2019 American Transplant Congress
The Need for Diabetic Medications after Pancreas Transplantation
Mount Sinai Hospital, New York, NY
*Purpose: Patients with diabetes mellitus can experience microvascular complications resulting in end organ damage ultimately necessitating pancreatic transplantation. While there is well documented improvement in…2019 American Transplant Congress
Can Cxcl8 Inhibitor (reparixin) Improve Islet Engraftment And Clinical Outcomes After Islet Allotransplantation? University Of Chicago Preliminary Results From A Phase 3 Multicenter Randomized, Double-blinded, Prospective Study.
1University of Chicago Medicine, Chicago, IL, 2Medical University of Gdansk, Gdansk, Poland
*Purpose: Reparixin is a novel CxCR1/2 chemokine receptor-blocking molecule, which has been shown improving islet engraftment in animal models. A multicenter trial was organized to…2019 American Transplant Congress
Pancreas Transplantation Outcomes – A Single Center Experience 400 Cases
*Purpose: Pancreas transplant is considered as an effective treatment strategy to restore long-term euglycemia and stabilize the multiorgan complications. By June 2019, our center performed…2019 American Transplant Congress
Pre-Operative C-Peptide Predicts Weight Gain after Pancreas Transplantation
Montefiore Medical Center, Bronx, NY
*Purpose: Transplant recipients are susceptible to metabolic syndrome as typified by hyperglycemia, central obesity and increased insulin resistance after transplant, which may precede the onset…2019 American Transplant Congress
Correlates of Significant Weight Changes Following Pancreas Alone Transplantation
University of Wisconsin, Madison, WI
*Purpose: Significant weight change is defined as unintentional weight gain of ≥ 7% of body weight or unintentional weight loss of > 5% in one…2019 American Transplant Congress
Optimizing Patient Blood Management in Simultaneous Kidney and Pancreas Transplantation
University of Wisconsin, Madison, WI
*Purpose: To identify a post-operative hematocrit (Hct) target for patients recovering from simultaneous kidney and pancreas (SPK) transplant and pancreas transplant alone (PTA) that is…2019 American Transplant Congress
Outcomes of Portal Vein Extension Grafts in Pancreas Transplantation: A Single-Centre Analysis
*Purpose: Surgical dogma suggests that portal vein extension grafts (PVEGs) in pancreas transplantation should be strenuously avoided, though the evidence-base is lacking. In our unit,…2019 American Transplant Congress
Use of Belatacept in Pancreas Transplantation
Kidney/Pancreas Transplantation, ITAC - Nephrology, Buenos Aires, Argentina
*Purpose: To review our experience with Belatacept in pancreas transplantation*Methods: Retrospective review including all patients receiving Belatacept after pancreas transplantation. Main objective is to review…2019 American Transplant Congress
Pictogram Tool to Improve Medication Adherence in Heart Transplant Families with Limited English Proficiency and Low Health Literacy
*Purpose: Rejection in heart transplant recipients significantly limits long-term survival, impairs quality of life, and increases both direct and indirect costs of care. Preventing rejection…2019 American Transplant Congress
Correlation between Self-Reported Medication Adherence and Side Effects in Transplant Recipients
*Purpose: Medication non-adherence (MNA) is a major risk factor for acute rejection and graft loss amongst all organ groups. It is unclear how medication side…
- « Previous Page
- 1
- …
- 648
- 649
- 650
- 651
- 652
- …
- 1683
- Next Page »